IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 189 filers reported holding IMMUNOGEN INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,504,265 | +38.2% | 1,796,110 | +64.3% | 0.01% | +50.0% |
| Q2 2023 | $20,624,775 | +586.8% | 1,092,993 | +39.8% | 0.00% | +300.0% |
| Q1 2023 | $3,003,006 | -23.3% | 782,033 | -0.9% | 0.00% | 0.0% |
| Q4 2022 | $3,914,957 | +0.4% | 789,306 | -3.3% | 0.00% | 0.0% |
| Q3 2022 | $3,901,000 | +16.1% | 816,072 | +9.3% | 0.00% | 0.0% |
| Q2 2022 | $3,361,000 | -11.6% | 746,862 | -6.5% | 0.00% | 0.0% |
| Q1 2022 | $3,803,000 | -31.4% | 798,902 | +7.0% | 0.00% | 0.0% |
| Q4 2021 | $5,540,000 | +29.2% | 746,659 | -1.3% | 0.00% | 0.0% |
| Q3 2021 | $4,289,000 | -5.0% | 756,484 | +10.4% | 0.00% | 0.0% |
| Q2 2021 | $4,516,000 | -31.1% | 685,309 | -15.4% | 0.00% | 0.0% |
| Q1 2021 | $6,559,000 | +23.2% | 809,799 | -1.9% | 0.00% | 0.0% |
| Q4 2020 | $5,326,000 | +88.9% | 825,727 | +5.4% | 0.00% | 0.0% |
| Q3 2020 | $2,819,000 | -22.0% | 783,083 | -0.3% | 0.00% | 0.0% |
| Q2 2020 | $3,613,000 | +36.1% | 785,406 | +0.9% | 0.00% | 0.0% |
| Q1 2020 | $2,654,000 | -28.2% | 778,582 | +7.5% | 0.00% | 0.0% |
| Q4 2019 | $3,698,000 | +120.0% | 724,428 | +4.3% | 0.00% | – |
| Q3 2019 | $1,681,000 | +8.0% | 694,765 | -3.2% | 0.00% | – |
| Q2 2019 | $1,557,000 | -7.7% | 717,711 | +15.4% | 0.00% | – |
| Q1 2019 | $1,686,000 | -42.0% | 622,135 | +2.8% | 0.00% | -100.0% |
| Q4 2018 | $2,907,000 | -50.0% | 605,422 | -1.5% | 0.00% | 0.0% |
| Q3 2018 | $5,818,000 | +9.5% | 614,495 | +12.5% | 0.00% | 0.0% |
| Q2 2018 | $5,312,000 | -14.5% | 546,088 | -7.6% | 0.00% | -50.0% |
| Q1 2018 | $6,214,000 | +100.1% | 590,690 | +22.0% | 0.00% | +100.0% |
| Q4 2017 | $3,105,000 | -26.0% | 484,168 | -11.7% | 0.00% | 0.0% |
| Q3 2017 | $4,195,000 | +2.1% | 548,486 | -5.1% | 0.00% | 0.0% |
| Q2 2017 | $4,108,000 | +141.9% | 577,840 | +31.7% | 0.00% | – |
| Q1 2017 | $1,698,000 | +118.8% | 438,917 | +15.4% | 0.00% | – |
| Q4 2016 | $776,000 | -21.1% | 380,401 | +3.7% | 0.00% | – |
| Q3 2016 | $983,000 | -20.7% | 366,832 | -8.8% | 0.00% | – |
| Q2 2016 | $1,239,000 | -68.9% | 402,416 | -13.9% | 0.00% | -100.0% |
| Q1 2016 | $3,980,000 | -37.7% | 467,157 | -0.8% | 0.00% | -50.0% |
| Q4 2015 | $6,393,000 | +42.2% | 471,119 | +0.6% | 0.00% | +100.0% |
| Q3 2015 | $4,496,000 | -42.2% | 468,290 | -13.4% | 0.00% | -50.0% |
| Q2 2015 | $7,777,000 | +63.8% | 540,850 | +1.9% | 0.00% | +100.0% |
| Q1 2015 | $4,749,000 | +64.3% | 530,662 | +12.0% | 0.00% | 0.0% |
| Q4 2014 | $2,891,000 | -39.5% | 473,890 | +5.0% | 0.00% | 0.0% |
| Q3 2014 | $4,781,000 | -52.4% | 451,497 | -46.7% | 0.00% | 0.0% |
| Q2 2014 | $10,042,000 | +54.3% | 847,488 | +94.5% | 0.00% | -50.0% |
| Q1 2014 | $6,506,000 | +1.7% | 435,771 | -0.0% | 0.00% | 0.0% |
| Q4 2013 | $6,396,000 | -56.8% | 435,981 | -49.8% | 0.00% | 0.0% |
| Q3 2013 | $14,794,000 | +111.3% | 869,256 | +106.0% | 0.00% | 0.0% |
| Q2 2013 | $7,002,000 | – | 422,055 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TWIN FOCUS CAPITAL PARTNERS, LLC | 140,000 | $2,090,000 | 2.48% |
| BB BIOTECH AG | 3,165,816 | $47,266,000 | 2.44% |
| SECTORAL ASSET MANAGEMENT INC | 3,623,786 | $54,103,000 | 2.22% |
| Lumbard & Kellner, LLC | 81,225 | $1,192,000 | 1.02% |
| Artal Group S.A. | 1,300,000 | $19,409,000 | 0.70% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 100,000 | $1,493,000 | 0.48% |
| Rhenman & Partners Asset Management AB | 73,702 | $1,100,000 | 0.33% |
| PINNACLE ASSOCIATES LTD | 883,647 | $13,193,000 | 0.26% |
| FIRST TRUST ADVISORS LP | 3,608,918 | $53,881,000 | 0.24% |
| Granahan Investment Management | 540,641 | $8,072,000 | 0.22% |